OICS v0.3.3 class · Healthcare

Generics & Consumer Health

ID GNX HC.PH.PHA.GNX

Makes generic or biosimilar medicines, off-patent or reformulated specialty drugs, over-the-counter and consumer-health products (including vitamins, dietary supplements and medical nutrition), active ingredients, or compounded drugs, for humans or animals; a drugmaker goes by what earns most, its own patented medicines or the rest.

Where it sits

Sector, group and industry above this class, as placed in the current release. The sector and the industry link to their companies.

Sector: HC Healthcare in the standard Medicines, medical technology and the delivery of care.
Group: HC.PH Medicines & Life Sciences Developing and making medicines, and the tools and services for it.
Industry: HC.PH.PHA Pharmaceuticals in the standard Selling approved medicines at scale.

Companies in this class

Companies whose primary class this is. The sector and industry pages and the screener count them the same way.

All companies1,258 Listed with filings866

Largest first Name Country

Counted by primary class: companies that are listed and have filings on FinancialFilings.

Company	Ticker	Country	Market cap	Filings
Me Today Limited	MEE	New Zealand	—	297
Newtree Co., Ltd.	270870	South Korea	—	295
Astra Industrial Group	1212	Saudi Arabia	—	293
EMB CO.,LTD.	278990	South Korea	—	293
NeutriSci International Inc.	NU.H	Canada	—	293
Lumiera Health Inc.	NHP.H	Canada	—	292
GLENMARK PHARMACEUTICALS LIMITED	4G8B	Singapore	—	291
DUOPHARMA BIOTECH BERHAD	—	Malaysia	—	290
CTCP Dược phẩm CPC1 Hà Nội	DTP	Viet Nam	—	289
SUDARSHAN PHARMA INDUSTRIES LIMITED	543828	India	—	289
Enlie Pharmaceutical JSC	BCP	Viet Nam	—	288
CTCP Dược Trung ương 3	TW3	Viet Nam	—	286
Dermapharm Holding SE	DMP	Germany	—	284
THE HYDRATION PHARMACEUTICALS COMPANY LIMITED	HPC	Australia	—	283
WAKAMOTO PHARMACEUTICAL CO.,LTD.	4512	Japan	—	281
Soiken Holdings Inc.	2385	Japan	—	279
SUCCESSMORE BEING PUBLIC COMPANY LIMITED	SCM	Thailand	—	277
BIFIDO. Co. Ltd	238200	South Korea	—	276
Bharat Immunologicals & Biologicals	524663	India	—	274
Macter International Limited	MACTER	Pakistan	—	273
Pharmala Biotech Holdings Inc.	MDMA	Canada	—	273
Cong ty Co phan Duoc - Vat tu Y te Dak Lak (Bamepharm)	DBM	Viet Nam	—	266
Shandong Boyuan Pharmaceutical&Chemical Co.,Ltd	301617	China	—	266
Traphaco High Tech JSC	CNC	Viet Nam	—	265
Công ty Cổ phần Xuất nhập khẩu Y tế DOMESCO	DMC	Viet Nam	—	262
Eastwood Bio-Medical Canada Inc.	EBM	Canada	—	262
SHANGHAI XIAO FANG PHARMACEUTICAL CO.,LTD.	603207	China	—	262
Công ty Cổ phần Traphaco	TRA	Viet Nam	—	260
CTCP Dược - Vật tư Y tế Nghệ An	NTF	Viet Nam	—	254
RHONE MA HOLDINGS BERHAD	—	Malaysia	—	251
Hurum Co., Ltd.	353190	South Korea	—	250
Irwin Naturals Inc.	IWIN	Canada	—	250
SUNZEN GROUP BERHAD	—	Malaysia	—	250
Euro-Med Laboratories Phil., Inc.	EURO	Philippines (the)	—	249
JBM (Healthcare) Limited	2161	Hong Kong	—	248
Optipharm.CO.,LTD	153710	South Korea	—	247
HAVN Life Sciences Inc.	HAVN	Canada	—	246
Amanta Healthcare Limited	AMANTA	India	—	245
KoBioLabs, Inc.	348150	South Korea	—	238
Corona Remedies Limited	CORONA	India	—	233
Mabpharm Limited	2181	Hong Kong	—	233
CTCP Dược phẩm Trung ương 2	DP2	Viet Nam	—	232
CTCP Sức khỏe Hồi sinh Việt Nam	NHV	Viet Nam	—	229
CTCP Dược Medipharco	MTP	Viet Nam	—	228
GREEN CROSS WellBeing Corporation	234690	South Korea	—	228
Green Zebras Spolka Akcyjna	GRZ	Poland	—	227
SHELTER PHARMA LIMITED	543963	India	—	219
RUBICON RESEARCH LIMITED	RUBICON	India	—	217
Anxo Pharmaceutical Co., Ltd.	6677	Taiwan	—	213
INTER PHARMA PUBLIC COMPANY LIMITED	IP	Thailand	—	212

Companies in Pharmaceuticals → Open in the screener →

Boundaries

Other names for this activity, and where neighboring activities go instead.

Also known as

genericsOTCAPI manufacturerbiosimilars

Not here

makes ingredients or drugs under contract for other drug companies → CRO Contract Research & Manufacturing
mostly its own patented medicines → RXB Branded Prescription Drugs or CMB Commercial Biotech

Sent here from

Other classes in Pharmaceuticals

Branded Prescription Drugs RXB HC.PH.PHA.RXB

Discovers, develops and markets branded prescription medicines or vaccines with approved products in at least three therapeutic areas, for humans or animals; a company moves between this class and Commercial Biotech only after two consecutive annual reports on the other side.

Also big pharma, innovative pharmaceuticals, animal health

Not here no approved product → CLB Clinical-Stage Biotech
Not here approved products in one or two therapeutic areas, research-led → CMB Commercial Biotech
Not here mostly generics, off-patent brands and over-the-counter products → GNX Generics & Consumer Health

Permanent link

https://financialfilings.com/oics/GNX/

This page is keyed by the class ID GNX. IDs are assigned in v0.3 and freeze at v1.0; from then on an ID is never renamed or reused, and if the class moves in the tree, its ID and this URL stay the same.

See it in the full standard Download the standard